Home/ Stocks/ HCWB

HCW Biologics Inc. Common Stock

HCWB XNAS

$1.68 -0.05 (-2.91%) ▼ 15-min delayed

Open

$1.66

High

$1.72

Low

$1.65

Volume

66.5K

Market Cap

$3.76M

About HCW Biologics Inc. Common Stock

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 35 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$121.7K	$-5,219,231	$-11.58
Q1 2026	$6.50M	$3.47M	$0.37
FY 2025	$54.2K	$-7,959,709	$-10.63
Q3 2025	$15.6K	$-4,554,336	$-2.02

TickerDaily Coverage

Stock Market Today, May 15, 2026: Penny Stocks Dominate Weekly Action as Biotech and AI Lead

Market News David Brooks · May 15, 2026

Friday's close on May 15, 2026 capped a week of extreme volatility dominated by micro-cap and penny...

Penny Stocks Under $5 Showing Triple-Digit Gains in May 2026

Penny Stocks Marcus Rivera · May 31, 2026

May 2026 has delivered some of the most explosive penny stock moves of the year. We break down the...

View All Coverage →

Get HCWB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on HCW Biologics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.